FIELD: medicine.
SUBSTANCE: invention relates to novel versions of peptides IL-21, where amino acids are delegated and/or replaced in region, consisting of amino acids No 83-96.
EFFECT: possibility of manufacturing medication for cancer treatment.
8 cl, 2 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PEPTIDES-DERIVATIVES IL-4 FOR MODULATION OF CHRONIC INFLAMMATORY RESPONSE AND TREATMENT OF AUTOIMMUNE DISEASES | 2009 |
|
RU2542375C2 |
| EXOTOXIN A PSEUDOMONAS WITH LESS IMMUNOGENIC T-AND/OR B-CELL EPITHOPES | 2012 |
|
RU2627216C2 |
| MUTANT POLYMERASES OF HEPATITIS B VIRUS | 2012 |
|
RU2625021C2 |
| IDENTIFICATION OF TUMOUR-ASSOCIATED ANTIGENS FOR DIAGNOSTICS AND THERAPY | 2013 |
|
RU2644686C2 |
| MTS GENE, MUTATIONS OF THIS GENE AND METHODS OF DIAGNOSIS OF MALIGNANT TUMORS USING MTS GENE SEQUENCE | 1995 |
|
RU2164419C2 |
| NEW MODULATORS AND METHODS OF THEIR APPLICATION | 2012 |
|
RU2627176C2 |
| BIOLOGICALLY ACTIVATED DRUGS BASED ON CYTOKINES AND METHODS OF USING THEM | 2019 |
|
RU2819307C2 |
| OLIGOPEPTIDE COMPOUNDS AND THEIR APPLICATIONS | 2009 |
|
RU2549675C2 |
| MUTATIONS OF MTS GENE IN EMBRYONIC LINE AND METHOD OF DETECTION OF PREDISPOSITION TO MALIGNANT TUMORS | 1995 |
|
RU2161309C2 |
| COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF TUMOUR | 2011 |
|
RU2636461C2 |
